ALLSTATE CORP (ALL)

US0200021014 - Common Stock

195.62  +0.1 (+0.05%)

After market: 195.62 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALL. ALL was compared to 141 industry peers in the Insurance industry. While ALL seems to be doing ok healthwise, there are quite some concerns on its profitability. ALL has a correct valuation and a medium growth rate. ALL also has an excellent dividend rating.



3

1. Profitability

1.1 Basic Checks

ALL had positive earnings in the past year.
ALL had a positive operating cash flow in the past year.
In multiple years ALL reported negative net income over the last 5 years.
In the past 5 years ALL always reported a positive cash flow from operatings.

1.2 Ratios

With a decent Return On Assets value of 3.61%, ALL is doing good in the industry, outperforming 67.86% of the companies in the same industry.
With an excellent Return On Equity value of 19.69%, ALL belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
Industry RankSector Rank
ROA 3.61%
ROE 19.69%
ROIC N/A
ROA(3y)-0.09%
ROA(5y)1.6%
ROE(3y)-1.33%
ROE(5y)6.42%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 6.58%, ALL is in line with its industry, outperforming 50.71% of the companies in the same industry.
Looking at the Operating Margin, with a value of 9.01%, ALL is in line with its industry, outperforming 48.57% of the companies in the same industry.
ALL's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.01%
PM (TTM) 6.58%
GM N/A
OM growth 3Y-73.97%
OM growth 5Y-45.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

ALL does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALL has less shares outstanding
ALL has a better debt/assets ratio than last year.

2.2 Solvency

The Debt to FCF ratio of ALL is 0.98, which is an excellent value as it means it would take ALL, only 0.98 years of fcf income to pay off all of its debts.
ALL has a Debt to FCF ratio of 0.98. This is in the better half of the industry: ALL outperforms 67.14% of its industry peers.
ALL has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.39, ALL perfoms like the industry average, outperforming 41.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.98
Altman-Z N/A
ROIC/WACCN/A
WACC8.47%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

5

3. Growth

3.1 Past

ALL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 362.68%, which is quite impressive.
The earnings per share for ALL have been decreasing by -35.31% on average. This is quite bad
The Revenue has grown by 11.67% in the past year. This is quite good.
ALL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.47% yearly.
EPS 1Y (TTM)362.68%
EPS 3Y-60.54%
EPS 5Y-35.31%
EPS Q2Q%382.72%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y10.86%
Revenue growth 5Y7.47%
Sales Q2Q%10.55%

3.2 Future

Based on estimates for the next years, ALL will show a very strong growth in Earnings Per Share. The EPS will grow by 94.56% on average per year.
Based on estimates for the next years, ALL will show a small growth in Revenue. The Revenue will grow by 5.99% on average per year.
EPS Next Y1713.23%
EPS Next 2Y359.52%
EPS Next 3Y185.3%
EPS Next 5Y94.56%
Revenue Next Year9.8%
Revenue Next 2Y8.87%
Revenue Next 3Y8.76%
Revenue Next 5Y5.99%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.88, the valuation of ALL can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of ALL is on the same level as its industry peers.
ALL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.55.
A Price/Forward Earnings ratio of 10.18 indicates a reasonable valuation of ALL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALL is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ALL to the average of the S&P500 Index (24.00), we can say ALL is valued rather cheaply.
Industry RankSector Rank
PE 11.88
Fwd PE 10.18

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALL is on the same level as its industry peers.
64.29% of the companies in the same industry are more expensive than ALL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.3
EV/EBITDA 9.54

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALL's earnings are expected to grow with 185.30% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y359.52%
EPS Next 3Y185.3%

7

5. Dividend

5.1 Amount

ALL has a Yearly Dividend Yield of 1.94%. Purely for dividend investing, there may be better candidates out there.
ALL's Dividend Yield is comparable with the industry average which is at 4.35.
Compared to an average S&P500 Dividend Yield of 2.36, ALL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.94%

5.2 History

On average, the dividend of ALL grows each year by 12.54%, which is quite nice.
ALL has paid a dividend for at least 10 years, which is a reliable track record.
ALL has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)12.54%
Div Incr Years14
Div Non Decr Years15

5.3 Sustainability

26.17% of the earnings are spent on dividend by ALL. This is a low number and sustainable payout ratio.
ALL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP26.17%
EPS Next 2Y359.52%
EPS Next 3Y185.3%

ALLSTATE CORP

NYSE:ALL (12/26/2024, 8:04:00 PM)

After market: 195.62 0 (0%)

195.62

+0.1 (+0.05%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners80.17%
Inst Owner Change0.51%
Ins Owners0.53%
Ins Owner Change-2.08%
Market Cap51.80B
Analysts79.23
Price Target225.9 (15.48%)
Short Float %0.9%
Short Ratio1.56
Dividend
Industry RankSector Rank
Dividend Yield 1.94%
Dividend Growth(5Y)12.54%
DP26.17%
Div Incr Years14
Div Non Decr Years15
Ex-Date11-29 2024-11-29 (0.92)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)198.67%
Min EPS beat(2)64.3%
Max EPS beat(2)333.04%
EPS beat(4)4
Avg EPS beat(4)117.63%
Min EPS beat(4)28.89%
Max EPS beat(4)333.04%
EPS beat(8)7
Avg EPS beat(8)68.67%
EPS beat(12)8
Avg EPS beat(12)47.92%
EPS beat(16)11
Avg EPS beat(16)40.32%
Revenue beat(2)0
Avg Revenue beat(2)-1.29%
Min Revenue beat(2)-2.51%
Max Revenue beat(2)-0.07%
Revenue beat(4)1
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)1.38%
Revenue beat(8)2
Avg Revenue beat(8)1.6%
Revenue beat(12)6
Avg Revenue beat(12)6.49%
Revenue beat(16)10
Avg Revenue beat(16)10.55%
PT rev (1m)6.85%
PT rev (3m)11.57%
EPS NQ rev (1m)1.93%
EPS NQ rev (3m)14.46%
EPS NY rev (1m)1.8%
EPS NY rev (3m)9.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.46%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)-1.58%
Valuation
Industry RankSector Rank
PE 11.88
Fwd PE 10.18
P/S 0.83
P/FCF 6.3
P/OCF 6.13
P/B 2.48
P/tB 2.93
EV/EBITDA 9.54
EPS(TTM)16.47
EY8.42%
EPS(NY)19.22
Fwd EY9.82%
FCF(TTM)31.04
FCFY15.87%
OCF(TTM)31.91
OCFY16.31%
SpS235.77
BVpS78.84
TBVpS66.73
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.61%
ROE 19.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 9.01%
PM (TTM) 6.58%
GM N/A
FCFM 13.17%
ROA(3y)-0.09%
ROA(5y)1.6%
ROE(3y)-1.33%
ROE(5y)6.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-73.97%
OM growth 5Y-45.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.98
Debt/EBITDA 1.31
Cap/Depr 40.6%
Cap/Sales 0.37%
Interest Coverage 250
Cash Conversion 136.46%
Profit Quality 199.95%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC8.47%
ROIC/WACCN/A
Cap/Depr(3y)39.76%
Cap/Depr(5y)46.22%
Cap/Sales(3y)0.66%
Cap/Sales(5y)0.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)362.68%
EPS 3Y-60.54%
EPS 5Y-35.31%
EPS Q2Q%382.72%
EPS Next Y1713.23%
EPS Next 2Y359.52%
EPS Next 3Y185.3%
EPS Next 5Y94.56%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y10.86%
Revenue growth 5Y7.47%
Sales Q2Q%10.55%
Revenue Next Year9.8%
Revenue Next 2Y8.87%
Revenue Next 3Y8.76%
Revenue Next 5Y5.99%
EBIT growth 1Y371.17%
EBIT growth 3Y-71.14%
EBIT growth 5Y-41.95%
EBIT Next Year2697.91%
EBIT Next 3Y237.24%
EBIT Next 5YN/A
FCF growth 1Y78.27%
FCF growth 3Y-8.57%
FCF growth 5Y-4.16%
OCF growth 1Y68.28%
OCF growth 3Y-8.34%
OCF growth 5Y-3.96%